research
evid
shown
activ
involv
apoptot
thu
want
determin
whether
infect
cell
regul
cell
cycl
progress
synchron
cell
maintain
minim
essenti
medium
mem
contain
serum
h
infect
strain
multipl
infect
moi
tissu
cultur
infect
dose
unit
per
cell
incub
mem
supplement
fetal
bovin
serum
fb
indic
time
point
postinfect
nuclear
dna
content
measur
use
propidium
iodid
pi
stain
fluorescenceactiv
cell
sort
fac
analysi
shown
fig
observ
obviou
accumul
cell
phase
synchron
cell
h
postinfect
examin
whether
cell
cycl
arrest
induc
associ
viru
replic
use
uv
lightirradi
equival
moi
infect
synchron
cell
cell
cycl
arrest
detect
cell
infect
uvtreat
mockinfect
cell
fig
histogram
analyz
quantit
curvefit
program
determin
percentag
cell
phase
fig
higher
percentag
cell
phase
h
postinfect
time
larger
popul
present
cell
mockinfect
cell
respect
cell
popul
phase
infect
uvtreat
decreas
significantli
compar
cell
compar
mockinfect
cell
fig
togeth
data
suggest
capabl
induc
phase
arrest
infect
cell
depend
upon
viru
replic
mani
host
molecul
particip
regul
transit
cyclincdk
complex
prb
cki
order
confirm
key
molecul
respons
cell
cycl
arrest
synchron
cell
assay
express
sever
host
transit
protein
western
blot
h
postinfect
shown
fig
decreas
cyclin
e
cell
compar
mockinfect
cell
contrast
signific
differ
observ
amount
mockinfect
cell
indic
time
point
postinfect
fig
indic
cell
cycl
arrest
involv
activ
observ
murin
downstream
target
cyclin
e
level
phosphoryl
retinoblastoma
prb
significantli
reduc
infect
fig
densitometr
analysi
confirm
amount
cyclin
e
well
prb
markedli
smaller
cell
mockinfect
cell
h
postinfect
fig
result
indic
infect
limit
express
cyclin
e
follow
inhibit
rb
phosphoryl
turn
lead
block
phase
cell
cycl
similar
observ
report
virus
measl
herp
simplex
viru
type
murin
influenza
indic
reduct
amount
cyclin
may
common
mechan
virus
includ
block
cell
cycl
progress
increas
research
data
shown
mani
virus
capabl
exploit
cell
cycl
arrest
effici
investig
whether
cell
cycl
arrest
phase
induc
infect
advantag
viru
replic
total
lysat
synchron
nonsynchron
cell
harvest
individu
h
postinfect
nonsynchron
cell
maintain
normal
mem
contain
serum
shown
fig
express
level
viral
protein
total
cell
lysat
synchron
cell
higher
nonsynchron
cell
determin
western
blot
densitometr
analysi
order
determin
whether
increas
viral
protein
express
would
facilit
progeni
viru
product
supernat
infect
cell
examin
viru
product
indirect
immunofluoresc
assay
ifa
expect
signal
seen
synchron
cell
compar
nonsynchron
cell
data
shown
evalu
cell
show
viru
product
increas
synchron
treatment
fig
consist
pattern
viral
protein
express
level
fig
result
indic
exploit
phase
cell
cycl
growth
result
indic
cell
cycl
arrest
cell
mediat
decreas
cyclin
e
research
data
shown
famili
share
mani
common
target
includ
cyclin
e
regul
cell
cycl
prompt
us
analys
whether
two
host
mirna
coregul
infect
involv
cell
cycl
arrest
induc
replic
thu
determin
express
level
mirna
synchron
cell
realtim
rtpcr
shown
fig
signific
upregul
fold
observ
synchron
cell
h
postinfect
compar
mockinfect
cell
contrast
express
level
obvious
chang
infect
compar
mockinfect
cell
fig
also
shown
regul
cell
cycl
progress
target
relev
transit
protein
therefor
determin
express
level
synchron
cell
found
obviou
chang
observ
compar
mockinfect
cell
fig
result
demonstr
infect
mediat
upregul
express
prompt
us
specul
may
involv
cell
cycl
arrest
valid
possibl
may
target
key
molecul
relat
cell
cycl
arrest
use
rna
hybrid
analys
found
seed
sequenc
possess
highest
score
probabl
target
cyclin
e
ccne
utr
fig
public
mirna
databas
rnahybrid
predict
cyclin
e
might
target
highli
conserv
bind
site
occur
utr
su
scrofa
cyclin
e
posit
su
scrofa
cyclin
e
mrna
found
complet
utr
su
scrofa
cyclin
predict
whether
su
scrofa
possess
highli
conserv
bind
site
bind
site
found
occur
speci
utr
gallu
gallu
cyclin
posit
bind
site
highli
homolog
utr
su
scrofa
cyclin
e
posit
therefor
dual
luciferas
report
assay
perform
investig
whether
directli
target
utr
cyclin
e
mrna
shown
fig
signific
decreas
rel
luciferas
activ
observ
cell
transfect
mimic
compar
neg
control
mirnc
rel
luciferas
activ
inhibitortr
cell
higher
aloneinfect
cell
addit
use
mutant
plasmid
fig
transfect
cell
found
rel
luciferas
activ
cell
obvious
chang
regardless
cotransfect
mirnc
inhibitor
mimic
compar
mockinfect
mirnctreat
cell
fig
collect
result
suggest
target
cyclin
e
mrna
utr
access
role
express
blockag
cycl
progress
cell
transfect
inhibitor
infect
h
cell
cycl
analyz
flow
cytometri
shown
fig
inhibit
express
rescu
phase
cell
cycl
block
time
popul
inhibitortr
cell
respect
compar
mockinfect
cell
popul
slightli
increas
cell
treatment
mimic
fig
use
western
blot
determin
express
cyclin
e
inhibitortr
cell
found
decreas
cyclin
e
well
reduct
level
rb
phosphoryl
also
recov
cell
inhibitor
treatment
fig
howev
treatment
mimic
obvious
reduc
express
cyclin
e
well
prb
cell
fig
result
demonstr
overexpress
induc
decreas
cyclin
e
express
follow
reduct
rb
phosphoryl
thu
lead
blockag
cell
cycl
phase
cell
data
demonstr
express
upregul
cell
regul
express
cyclin
e
requir
promot
cell
phase
thu
want
assess
effect
replic
cell
transfect
specif
inhibitor
control
mirnc
follow
infect
moi
h
western
blot
analysi
show
express
level
viral
protein
significantli
decreas
treatment
inhibitor
fig
mimic
treatment
express
protein
slightli
increas
compar
aloneinfect
cell
fig
expect
obviou
chang
observ
express
level
protein
mirnctreat
cell
fig
supernat
inhibitortr
cell
collect
determin
viru
product
shown
fig
evalu
cell
show
viru
product
inhibit
significantli
decreas
p
compar
mirnctreat
cell
treatment
mimic
slightli
increas
viru
product
compar
aloneinfect
cell
fig
result
togeth
data
shown
fig
indic
upregul
benefici
growth
contribut
phase
cell
cell
cycl
arrest
report
infect
mani
virus
mhv
infect
report
inhibit
host
cellular
dna
synthesi
block
phase
progress
dbt
cell
cyclin
cyclin
e
nonstructur
protein
might
respons
mhv
induc
cell
cycl
cyclin
decreas
observ
measl
viru
mv
infect
cell
may
contribut
mvinduc
cell
cycl
infect
avian
influenza
viru
report
induc
accumul
cell
phase
infect
cell
cyclin
cyclin
e
protein
interact
rhoarb
arrest
demonstr
promot
influenza
viru
replic
evidenc
increas
viral
protein
express
viru
product
phasearrest
mnv
infect
shown
induc
arrest
phase
inhibit
transit
provid
favour
environ
viral
infect
degrad
cyclin
e
decreas
cyclin
activ
degrad
cyclin
decreas
cyclin
activ
phosphoryl
rb
regul
primarili
complex
cyclin
later
cyclin
activ
critic
step
phase
transit
similar
virus
infect
lead
decreas
express
cyclin
cyclin
e
follow
downregul
rb
phosphoryl
therebi
block
cell
cycl
progress
phase
furthermor
infectioninduc
arrest
help
facilit
viral
replic
might
associ
better
adapt
infect
condit
mirna
contribut
cell
cycl
control
via
target
varieti
key
molecul
cell
cycl
machineri
coordin
regul
gene
increas
research
data
shown
mani
virus
exploit
host
cellular
mirna
modifi
cell
cycl
control
viral
replic
decreas
express
hbv
infect
shown
lead
upregul
target
cyclin
follow
modul
activ
therebi
possibl
contribut
viral
replic
human
cytomegaloviru
report
inhibit
express
target
follow
promot
cell
enter
transit
therebi
benefit
viral
upregul
express
infect
tlymphocyt
cell
line
demonstr
promot
cell
cycl
progress
via
target
downregul
protein
neg
regul
transit
facilit
viral
present
studi
found
mirna
includ
exhibit
signific
upregul
synchron
cell
predic
put
target
found
ccne
cyclin
e
direct
target
cell
luciferas
assay
although
direct
evid
cyclin
might
also
target
cell
due
absenc
complet
utr
su
scrofa
cyclin
avail
found
limit
express
treatment
inhibitor
promot
cyclin
e
protein
express
synchron
cell
cell
cycl
arrest
restor
inhibit
express
might
implic
also
regul
express
cyclin
protein
via
direct
interact
target
sequenc
locat
utr
su
scrofa
cyclin
observ
cyclin
e
addit
found
promot
effici
replic
confirm
decreas
viral
protein
express
viru
product
cell
inhibit
express
given
invers
regul
infect
suggest
involv
augment
replic
mainli
modul
abil
downregul
express
ccne
overal
result
show
upregul
mean
decreas
ccne
level
may
benefit
viral
replic
block
cell
cycl
progress
conclus
result
demonstr
replic
block
cell
cycl
progress
phase
produc
favour
condit
viral
protein
express
viru
product
cell
cycl
arrest
may
regul
host
via
mediat
cyclin
e
degrad
enhanc
growth
knowledg
role
regul
cell
cycl
control
provid
import
inform
understand
molecular
mechan
infect
cell
cultur
minim
essenti
medium
mem
supplement
fetal
bovin
serum
fb
lglutamin
penicillinstreptomycin
subconflu
cultur
cell
starv
without
serum
addit
h
synchron
synchron
cell
mock
infect
infect
strain
multipl
infect
moi
one
tissu
cultur
infect
dose
unit
per
cell
h
viru
adsorpt
cell
treat
medium
contain
fb
harvest
indic
time
postinfect
cell
cycl
analysi
western
blot
rabbit
goat
mous
antibodi
cyclin
cyclin
e
phosphorylatedrb
prb
purchas
santa
cruz
biotechnolog
horseradish
peroxidas
hrp
conjug
secondari
antibodi
purchas
sigma
fluorescein
isothiocyan
fitc
conjug
secondari
antibodi
purchas
dako
flow
cytometri
use
analyz
cell
cycl
describ
brief
adher
cell
mock
infect
infect
h
harvest
trysin
wash
phosphatebuff
salin
pb
pellet
centrifug
uvinactiv
prepar
use
describ
cell
fix
ethanol
overnight
stain
nuclear
dna
content
propidium
iodid
pi
mgml
rnase
room
temperatur
rt
min
determin
pistain
cell
perform
use
fluorescenceactiv
cell
sort
fac
bd
fac
ii
least
cell
count
sampl
data
analys
use
modfit
lt
version
veriti
softwar
hous
total
rna
extract
synchron
cell
infect
use
trizol
reagent
invitrogen
quantit
revers
transcriptasepolymeras
chain
reaction
qrtpcr
use
determin
express
level
mirna
accord
protocol
mircut
mirna
cdna
kit
tiangen
biotech
co
ltd
beij
briefli
extract
rna
polyadenyl
first
strand
complementari
dna
synthes
use
oligo
dt
snrna
use
normal
primer
mirna
amplif
includ
univers
primer
mir
specif
forward
primer
f
f
f
f
snrna
f
snrna
r
rel
express
analyz
use
method
entir
utr
target
gene
su
scrofa
cyclin
e
amplifi
porcin
mrna
rtpcr
clone
downstream
luciferas
open
read
frame
orf
vector
invitrogen
primer
ccne
f
ccne
r
ccne
mf
ccne
mr
use
creat
plasmid
utr
wildtyp
utr
mutant
respect
singl
restrict
enzym
cut
site
xbai
vector
prltk
promega
also
use
cotransfect
vector
dual
luciferas
analysi
experi
cell
grown
starv
h
plate
transfect
investig
function
cell
purchas
mimic
inhibitor
genepharma
co
ltd
shanghai
china
synchron
cell
transfect
mimicsinhibitor
neg
control
mirnanc
genepharma
sequenc
caguacuuuuguguaguacaa
final
concentr
nmoll
use
lipofectamin
invitrogen
follow
manufactur
procedur
twelv
hour
transfect
cell
transfect
ng
utr
utr
plasmid
ng
prltk
twentyfour
hour
later
cell
wash
mock
infect
infect
strain
bjw
moi
maintain
mem
supplement
fb
incub
cell
harvest
h
infect
analyz
luciferas
activ
western
blot
luciferas
assay
perform
use
dualluciferas
report
assay
system
accord
manufactur
instruct
promega
luminesc
intens
firefli
luciferas
normal
renilla
luciferas
result
express
rel
luciferas
activ
indirect
immunofluoresc
assay
ifa
use
determin
progeni
product
describ
minor
modif
briefli
monolay
cell
infect
supernat
synchron
nonsynchron
cell
incub
h
fixat
paraformaldehydepb
cell
incub
rabbit
antibodi
dilut
skim
powderpb
rt
h
follow
fluorescein
isothiocyan
fitc
conjug
antirabbit
immunoglobulin
g
sigma
rt
h
cell
examin
fluoresc
microscopi
cell
count
random
six
field
view
whole
cell
lysat
extract
differ
time
point
infect
prepar
nuclear
extract
kit
activ
motif
follow
manufactur
protocol
cell
lysat
extract
dilut
sampl
buffer
boil
min
protein
extract
subject
sodium
dodecyl
sulfatepolyacrylamid
gel
electrophoresi
sdspage
transfer
nitrocellulos
membran
membran
block
tbst
block
buffer
mm
trishcl
ph
mm
nacl
tween
contain
dri
skim
milk
powder
rt
h
prevent
nonspecif
bind
membran
incub
antibodi
rais
cyclin
cyclin
e
prb
rt
h
three
wash
tbst
buffer
membran
incub
horseradish
peroxidaseconjug
secondari
antibodi
dilut
block
buffer
rt
h
immunoreact
band
detect
enhanc
chemiluminesc
system
kodak
imag
station
averag
valu
three
independ
experi
analyz
oneway
analysi
varianc
student
test
result
repres
mean
standard
deviat
sd
mean
differ
group
consid
signific
p
valu
cite
articl
quan
r
et
al
involv
phase
cell
cycl
arrest
induc
porcin
circoviru
type
replic
sci
rep
doi
